Benjamin Edwards Inc. Raises Position in Corteva, Inc. $CTVA

Key Points

• Benjamin Edwards Inc. raised its stake in Corteva by 1.7%, buying 12,393 shares to hold 721,749 shares (~$48.38M); institutional investors now own 81.54% of CTVA and several other funds also adjusted their positions.
• Insider Brian Titus sold 8,311 shares for about $636,207 (average $76.55), cutting his holding by ~50.7%; corporate insiders own only 0.15% of the stock.
• Corteva reported Q earnings of $0.22/share (in line) but revenue missed at $3.91B vs. $4.23B expected, set FY2026 guidance of $3.45–$3.70 EPS (analysts expect 3.62), and declared a $0.18 quarterly dividend (0.9% yield) with a consensus price target of $86.38 ("Moderate Buy").

Benjamin Edwards Inc. raised its holdings in Corteva, Inc. (NYSE:CTVA - Free Report) by 1.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 721,749 shares of the company's stock after buying an additional 12,393 shares during the period. Benjamin Edwards Inc. owned approximately 0.11% of Corteva worth $48,378,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CTVA. Brighton Jones LLC boosted its position in Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company's stock valued at $888,000 after buying an additional 11,760 shares during the period. Woodline Partners LP boosted its position in Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company's stock valued at $3,645,000 after buying an additional 16,644 shares during the period. EverSource Wealth Advisors LLC boosted its position in Corteva by 62.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company's stock valued at $191,000 after buying an additional 980 shares during the period. Cresset Asset Management LLC boosted its position in Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company's stock valued at $526,000 after buying an additional 181 shares during the period. Finally, Jump Financial LLC purchased a new position in Corteva in the 2nd quarter valued at approximately $1,464,000. Hedge funds and other institutional investors own 81.54% of the company's stock.

Insider Buying and Selling

In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.15% of the stock is owned by corporate insiders.

Corteva Price Performance

Corteva stock opened at $80.97 on Friday. The stock has a market cap of $54.36 billion, a P/E ratio of 51.24, a price-to-earnings-growth ratio of 2.77 and a beta of 0.59. The company has a fifty day simple moving average of $80.39 and a 200-day simple moving average of $72.12. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. The business had revenue of $3.91 billion during the quarter, compared to analysts' expectations of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company's revenue for the quarter was down 1.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts expect that Corteva, Inc. will post 3.62 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva's dividend payout ratio (DPR) is currently 45.57%.

Analysts Set New Price Targets

CTVA has been the subject of several recent research reports. BNP Paribas Exane raised their price target on shares of Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. Berenberg Bank raised their price target on shares of Corteva from $68.00 to $78.00 and gave the company a "hold" rating in a research report on Thursday, March 26th. Bank of America raised their price target on shares of Corteva from $80.00 to $82.00 and gave the company a "buy" rating in a research report on Thursday, January 8th. Wells Fargo & Company lifted their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 21st. Finally, Jefferies Financial Group lifted their price objective on shares of Corteva from $85.00 to $95.00 and gave the stock a "buy" rating in a research report on Monday, March 2nd. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $86.38.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.